Results 21 - 40 of 1,047 for All Library Resources
Sorted by:
Sorted by:
Date-oldestOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 21 |
Material Type: Newspaper Article
|
|
Merck Revises Regulatory Filing Timeline for MK-0524B, an Investigational Fixed-Dose Combination of MK-0524A and SimvastatinBusiness Wire, 2006-09-29COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 22 |
Material Type: Newspaper Article
|
|
Schering AG and Biogen Idec Announce Start of the ZEAL Phase III Clinical Trial With Anti-Cancer Drug Zevalin(R)Business Wire, 2006-10-05COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 23 |
Material Type: Newspaper Article
|
|
IDM Pharma Submits New Drug Application to the FDA for Junovan(TM) (mifamurtide) in the Treatment of OsteosarcomaBusiness Wire, 2006-10-26COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 24 |
Material Type: Newspaper Article
|
|
Synta Pharmaceuticals Announces FDA Fast Track Designation for STA-4783 in Metastatic MelanomaBusiness Wire, 2006-11-15COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 25 |
Material Type: Newspaper Article
|
|
Depomed Announces Strong Positive Phase II Trial Results for Once Daily Gabapentin GR(TM) to Treat Symptoms of Diabetic Peripheral NeuropathyBusiness Wire, 2006-12-12COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 26 |
Material Type: Newspaper Article
|
|
GenVec Announces Completion of Interim Safety Data Analysis for Phase II/III Trial with TNFerade(TM) in Pancreatic CancerBusiness Wire, 2006-12-14COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 27 |
Material Type: Newspaper Article
|
|
Gilead Announces Preliminary Results From Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic FibrosisBusiness Wire, 2006-12-19COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 28 |
Material Type: Newspaper Article
|
|
FDA Approves New Indication for INVANZ(R) (ertapenem) for the Prevention of Surgical Site Infections (SSI) following Elective Colorectal Surgery in AdultsBusiness Wire, 2006-12-20COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 29 |
Material Type: Newspaper Article
|
|
REPEAT/FDA Approves New Indication for INVANZ(R) (ertapenem) for the Prevention of Surgical Site Infections (SSI) following Elective Colorectal Surgery in AdultsBusiness Wire, 2006-12-21COPYRIGHT 2006 Business Wire, Inc.Digital Resources/Online E-Resources |
| 30 |
Material Type: Newspaper Article
|
|
Biogen Idec Initiates Phase III Trial of Galiximab for Follicular Non-Hodgkin's LymphomaBusiness Wire, 2007-01-25COPYRIGHT 2007 Business Wire, Inc.Digital Resources/Online E-Resources |
| 31 |
Material Type: Newspaper Article
|
|
Oscient Pharmaceuticals Completes Enrollment in Phase IV Trial of FACTIVE TabletsBusiness Wire, 2007-01-26COPYRIGHT 2007 Business Wire, Inc.Digital Resources/Online E-Resources |
| 32 |
Material Type: Newspaper Article
|
|
Phase III Trial of Progesterone for the Prevention of Preterm Birth in Women with a Previous Preterm Birth Earlier than 35 Weeks Does Not Meet EndpointsBusiness Wire, 2007-02-04COPYRIGHT 2007 Business Wire, Inc.Digital Resources/Online E-Resources |
| 33 |
Material Type: Newspaper Article
|
|
Zelos Therapeutics' Ostabolin-C(TM) Increases Bone Mineral Density in Phase 2 Osteoporosis TrialBusiness Wire, 2007-02-08COPYRIGHT 2007 Business Wire, Inc.Digital Resources/Online E-Resources |
| 34 |
Material Type: Newspaper Article
|
|
Gilead Announces 24-Week Results from Phase II Study of Investigational HIV Integrase Inhibitor GS 9137Business Wire, 2007-03-01COPYRIGHT 2007 Business Wire, Inc.Digital Resources/Online E-Resources |
| 35 |
Material Type: Newspaper Article
|
|
KAI Pharmaceuticals Presents Encouraging Phase 1/2 Results of a Novel Treatment for Heart AttackBusiness Wire, 2007-03-25COPYRIGHT 2007 Business Wire, Inc.Digital Resources/Online E-Resources |
| 36 |
Material Type: Newspaper Article
|
|
VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual MeetingBusiness Wire, 2007-05-09COPYRIGHT 2007 Business Wire, Inc.Digital Resources/Online E-Resources |
| 37 |
Material Type: Newspaper Article
|
|
Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic FibrosisBusiness Wire, 2007-05-29COPYRIGHT 2007 Business Wire, Inc.Digital Resources/Online E-Resources |
| 38 |
Material Type: Newspaper Article
|
|
Second Phase III Study Evaluating Gilead's Viread(R) for the Treatment of Chronic Hepatitis B Virus Meets Primary EndpointBusiness Wire, 2007-06-25COPYRIGHT 2007 Business Wire, Inc.Digital Resources/Online E-Resources |
| 39 |
Material Type: Newspaper Article
|
|
Alnylam Initiates Phase II Clinical Trial to Evaluate Safety and Anti-viral Efficacy of ALN-RSV01 in the Treatment of Respiratory Syncytial Virus (RSV) InfectionBusiness Wire, 2007-06-26COPYRIGHT 2007 Business Wire, Inc.Digital Resources/Online E-Resources |
| 40 |
Material Type: Newspaper Article
|
|
Geron Initiates Clinical Trial of Telomerase Inhibitor Drug in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung CancerBusiness Wire, 2007-07-09COPYRIGHT 2007 Business Wire, Inc.Digital Resources/Online E-Resources |
Results 21 - 40 of 1,047 for All Library Resources
Sorted by:
Sorted by:
Date-oldestOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Refine My Results
Creation Date
- Before 2005 (9)
- 2005 To 2008 (77)
- 2009 To 2012 (204)
- 2013 To 2017 (318)
- After 2017 (440)
-
More options
New Records
Subject
- Clinical Trials (608)
- Pharmaceutical Industry (574)
- Care And Treatment (288)
- Cancer (167)
- Biological Products Industry (149)
- Drug Therapy (138)
- Medical Research (135)
- Biotechnology Industry (115)
- Medicine, Experimental (103)
- Health Aspects (99)
- Antineoplastic Agents (66)
- Chemotherapy (62)
- Metastasis (60)
- Infection (56)
- Patient Outcomes (56)
- Immunotherapy (52)
- Antimitotic Agents (50)
- Vaccines (42)
- Biotechnology Industries (41)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||